)
Visual
test
ESSA Pharma
ESSA Pharma (EPIX) investor relations material
ESSA Pharma has been acquired
ESSA Pharma AGM 2025 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.AGM 2025 summary3 Oct, 2025
Opening remarks and agenda
Meeting held virtually, allowing security holders to participate, submit questions, and vote electronically via Computershare platform.
Rules for orderly conduct and voting procedures were outlined at the start.
David Parkinson chaired the meeting, with David Wood as Secretary and Dave Baines as scrutineer.
Corporate governance
Notice of meeting was sent in accordance with legal requirements, and quorum was confirmed as present.
Meeting was declared properly constituted for business transactions.
Shareholder proposals
Security holders considered and voted on a special resolution for a plan of arrangement involving multiple entities under a Business Combination Agreement.
Shareholders also considered a non-binding advisory resolution on executive compensation related to the arrangement.
Voluntary liquidation and dissolution of the company was proposed if the arrangement was not approved.
Appointment of PricewaterhouseCoopers LLP or another qualified liquidator was proposed in the event of liquidation.
Explain the future date of the arrangement agreement
What specific executive compensation was approved?
Clarify the multiple approval thresholds for arrangement
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from ESSA Pharma
- Phase 1 combo data show 81% PSA90; phase 2 readout expected mid-2025.EPIX
Jefferies 2024 Global Healthcare Conference1 Feb 2026 - Masofaniten shows strong early efficacy in prostate cancer trials, with key phase II data due next year.EPIX2024 Cantor Fitzgerald Global Healthcare Conference20 Jan 2026
- Shareholders to vote on cash acquisition, CVRs, and potential liquidation; board recommends approval.EPIXProxy Filing2 Dec 2025
- Shareholders are urged to approve a cash acquisition and CVR deal, with liquidation as the alternative.EPIXProxy Filing2 Dec 2025
- Annual meeting to vote on board size, director elections, pay, and auditor, with strong governance focus.EPIXProxy Filing2 Dec 2025
- Shareholders to receive cash and CVRs in XenoTherapeutics acquisition, unanimously board-approved.EPIXProxy Filing2 Dec 2025
- Shareholders to vote on acquisition, capital reduction, and cash distribution before winding up.EPIXProxy Filing2 Dec 2025
- Shareholders to receive cash and CVRs in acquisition; board unanimously supports approval.EPIXProxy Filing2 Dec 2025
- $80M capital return and winding-up transaction with Xeno; due bill trading set for August 19–25, 2025.EPIXProxy Filing2 Dec 2025
- US $80 million distribution and XenoTherapeutics acquisition set for shareholder approval.EPIXProxy Filing2 Dec 2025
ESSA Pharma
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage